trending Market Intelligence /marketintelligence/en/news-insights/trending/Nc--9oOYPsOIPs4ZAluiRA2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Bausch seeks to redeem $1.24B of senior notes

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Bausch seeks to redeem $1.24B of senior notes

Bausch Health Companies Inc. issued a conditional redemption notice for $1.24 billion of its outstanding 5.875% senior notes due 2023.

The company will redeem the notes only if it generates gross proceeds of at least $2.50 billion from its offering of $1.25 billion each of its 5.000% notes due 2028 and 5.250% notes due 2030.

The offering is expected to close Dec. 30.

In addition to redeeming its 5.875% notes, Bausch intends to use the gross proceeds from the offering to pay the amounts it owes for the $1.21 billion settlement of a class-action lawsuit, which claimed that the company failed to warn investors amid a drastic drop in share price beginning in 2015.

Laval, Quebec-based Bausch develops and commercializes eye, skin and digestive system treatments.